Free Trial

Short Interest in Aeluma, Inc. (NASDAQ:ALMU) Rises By 18.6%

Aeluma logo with Manufacturing background
Image from MarketBeat Media, LLC.

Key Points

  • Short interest rose 18.6% in April to 3,683,558 shares, equal to 24.0% of shares sold short and a days-to-cover ratio of 1.6 (average volume 2,352,777).
  • Significant insider selling occurred recently: major shareholder Mark N. Tompkins sold 37,500 shares and CEO Jonathan Klamkin sold 50,000 shares, with insiders offloading 179,500 shares in the last 90 days and owning 14.70% of the stock.
  • Aeluma trades around $19.17 with a market cap of about $345.1M and a negative PE; analysts have a consensus rating of Moderate Buy and a consensus target price of $25.33.
  • MarketBeat previews the top five stocks to own by June 1st.

Aeluma, Inc. (NASDAQ:ALMU - Get Free Report) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totaling 3,683,558 shares, a growth of 18.6% from the March 31st total of 3,106,499 shares. Currently, 24.0% of the shares of the company are sold short. Based on an average trading volume of 2,352,777 shares, the days-to-cover ratio is presently 1.6 days.

Aeluma Stock Up 1.4%

ALMU stock opened at $19.17 on Thursday. The firm has a market capitalization of $345.12 million and a PE ratio of -136.92. Aeluma has a twelve month low of $9.64 and a twelve month high of $25.88. The stock has a 50-day simple moving average of $15.29 and a two-hundred day simple moving average of $16.03.

Insider Transactions at Aeluma

In other news, major shareholder Mark N. Tompkins sold 37,500 shares of the stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $15.74, for a total transaction of $590,250.00. Following the completion of the transaction, the insider owned 1,824,988 shares in the company, valued at approximately $28,725,311.12. This represents a 2.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jonathan Klamkin sold 50,000 shares of the stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $18.05, for a total value of $902,500.00. Following the transaction, the chief executive officer owned 1,429,398 shares of the company's stock, valued at $25,800,633.90. The trade was a 3.38% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 179,500 shares of company stock worth $2,879,745. 14.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Caitong International Asset Management Co. Ltd purchased a new position in Aeluma during the 4th quarter valued at about $27,000. Quantbot Technologies LP purchased a new position in Aeluma during the 3rd quarter valued at about $29,000. BNP Paribas Financial Markets grew its holdings in Aeluma by 79.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,934 shares of the company's stock valued at $31,000 after buying an additional 855 shares in the last quarter. Osaic Holdings Inc. purchased a new position in Aeluma during the 2nd quarter valued at about $32,000. Finally, State of Wyoming purchased a new position in Aeluma during the 4th quarter valued at about $35,000.

Analyst Ratings Changes

Several research analysts have recently weighed in on ALMU shares. Williams Trading set a $25.00 price target on Aeluma in a research note on Tuesday, March 3rd. UBS Group reiterated a "buy" rating on shares of Aeluma in a research note on Tuesday, March 3rd. Benchmark reiterated a "buy" rating and set a $25.00 price target on shares of Aeluma in a research note on Tuesday, March 3rd. Freedom Capital upgraded Aeluma to a "strong-buy" rating in a research note on Tuesday, March 31st. Finally, Weiss Ratings restated a "sell (d-)" rating on shares of Aeluma in a research note on Monday, April 20th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $25.33.

Get Our Latest Stock Analysis on Aeluma

Aeluma Company Profile

(Get Free Report)

Aeluma, Inc develops optoelectronic and electronic devices in the United States. The company manufactures semiconductor materials and chips using compound semiconductors on diameter substrates that are used to manufacture mass market microelectronics. It offers its devices for use in mobile, automotive, AI, defence and aerospace, communication, AR/VR, and HPC applications, as well as laser emitters, transistors for integrated circuits, quantum photonic circuits, and solar cells applications. Aeluma, Inc was formerly known as Parc Investments, Inc and changed its name to Aeluma, Inc June 2021.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Aeluma Right Now?

Before you consider Aeluma, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aeluma wasn't on the list.

While Aeluma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines